Login to Your Account

Kymab Ramps Up Efforts for Antibody Partnerships, R&D

By Nuala Moran
Staff Writer

Tuesday, October 30, 2012
Kymab Ltd. called up two industry veterans to help with the commercialization of its new platform technology for generating monoclonal antibodies in transgenic mice, as it prepares both to out-license access to the technology and use it to start an internal drug discovery effort.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription